Skip to main content

Table 4 Logistic regression analyses of associations between SNPs and risk of postoperative inadequate analgesia

From: Single nucleotide polymorphisms associated with postoperative inadequate analgesia after single-port VATS in Chinese population

Gene

SNP

Model

Genotype

Adequate analgesia

Inadequate analgesia

OR (95% CI) unadjusted

P-Value unadjusted

OR (95% CI) adjusted

P-Value adjusted

ESR1

rs9340799

Recessive

A/A-G/A

99 (91.7%)

89 (98.9%)

1.00

0.01

1.00

0.020

G/G

9 (8.3%)

1 (1.1%)

0.12 (0.02–0.99)

0.13 (0.02–1.08)

P2RY12

rs3732765

Dominant

G/G

76 (70.4%)

75 (83.3%)

1.00

0.031

1.00

0.180

G/A-A/A

32 (29.6%)

15 (16.7%)

0.48 (0.24–0.95)

0.61 (0.29–1.28)

SCN11A

rs33985936

Dominant

C/C

89 (82.4%)

66 (73.3%)

1.00

0.12

1.00

0.042

T/C-T/T

19 (17.6%)

24 (26.7%)

1.70 (0.86–3.37)

2.15 (1.02–4.52)

 

rs11709492

Dominant

C/C

51 (47.2%)

56 (62.2%)

1.00

0.03

1.00

0.005

T/C-T/T

57 (52.8%)

34 (37.8%)

0.54 (0.31–0.96)

0.41 (0.22–0.77)

SCN10A

rs6795970

Dominant

G/G

84 (77.8%)

59 (65.6%)

1.00

0.06

1.00

0.026

G/A-A/A

24 (22.2%)

31 (34.4%)

1.84 (0.98–3.45)

2.14 (1.09–4.21)

SCN9A

rs6746030

Dominant

G/G

94 (87%)

86 (95.6%)

1.00

0.032

1.00

0.067

G/A-A/A

14 (13%)

4 (4.4%)

0.31 (0.10–0.99)

0.35 (0.10–1.16)

 

3312G > T

Dominant

G/G

96 (88.9%)

66 (73.3%)

1.00

0.005

1.00

0.011

T/G-T/T

12 (11.1%)

24 (26.7%)

2.91 (1.36–6.22)

2.85 (1.25–6.51)

TAOK3

rs1277441

Dominant

T/T

33 (30.6%)

40 (44.4%)

1.00

0.044

1.00

0.13

T/C-C/C

75 (69.4%)

50 (55.6%)

0.55 (0.31–0.99)

0.61 (0.32–1.15)

  1. Abbreviations: CI confidence intervals, ESR1 estrogen receptor 1, OR odds ratios, P2RY12 purinergic receptor P2Y12, SCN11A sodium voltage-gated channel alpha subunit 11, SCN10A sodium voltage-gated channel alpha subunit 10, SCN9A sodium voltage-gated channel alpha subunit 9, SNP single nucleotide polymorphism, TAOK3 TAO kinase 3